The Pharmacist September/October 2018 - Page 7

In brief visit for more 68-year-old man jailed over £60k unlicensed drugs stash A 68-year-old Surrey man was sentenced to a year in prison for dealing around 60,640 doses of unlicensed medicines, including tramadol. nation in the case of a no-deal Brexit. Best for Britain supporter and Pontypridd MP Owen Smith said: ‘I don’t remember anyone warning that Brexit would mean we’d have to stockpile drugs or that this would cost the NHS and taxpayers up to £2bn. Maybe they should have slapped that on the side of the bus. Every day it seems as though there is another hidden cost being revealed.’ • For more on Brexit, see page 12 3 PSNC negotiates flu vaccine fee hike to £9.48 as service goes from ‘strength to strength’ The fee for the flu vaccination service has increased by 34p to £7.98 per administered dose plus an additional fee of £1.50 per vaccination, the Pharmaceutical Services Negotiating Committee (PSNC) has announced. Other ‘key improvements’ on the service that PSNC has arranged with NHS England include allowing contractors to administer vaccinations in patients’ homes and allowing pharmacies to claim payments for the service electronically, it said. Contractors now only require face-to-face flu training every three years and are no longer required to register to offer the service with the NHS Business Services Authority (NHS BSA). Social care workers and hospice care workers have been added to the ‘at-risk’ group eligible for the service. Following the imp lementation of the General Data Protection Regulations (GDPR), the service’s consent form and record form have been separated. PSNC director of NHS services Alastair Buxton said: ‘The service continues to go from strength to strength and I’m looking forward to seeing pharmacies vaccinating record numbers of patients once again this year. ‘The service is just one way in which pharmacies are helping to support their patients and the wider NHS and we were very pleased to see the clear recognition of that value in the negotiations this year.’ Pharmacist Support chief steps down Superdrug launches £99 Botox service Pharmacist Support chief executive Diane Leicester-Hallam has stepped down after nine years in post and taken up a new role at the Pharmacists’ Defence Association (PDA). Superdrug announced in August it will offer cosmetic treatments on the high street, including Botox and fillers, as part of a new service. Nurses will be trained to give the treatments, which will start at £99. 4 £112m to see a further 1,500 pharmacists in general practice by the end of the three-year programme. The Department of Health and Social Care (DHSC) said pharmacy integration programmes including the Pharmacy Integration Fund (PhIF) will continue to develop and be evaluated. This will inform future decisions and identify the most cost-effective opportunities to improve service quality and relieve pressure in other parts of the NHS, it said. The RCGP said: ‘Many practices are concerned that they will not be able to afford to continue to employ their pharmacists once this funding ends, unless additional recurrent funding is provided.’ Extend GP pharmacist funding, GP body urges Money allocated for practice-based pharmacists through the GP Forward View (GPFV) programme should be extended after the initial round of funding ends, the Royal College of General Practitioners (RCGP) has urged. The GPFV was launched in 2016 to support general practice services with an extra £2.4bn a year in funding by 2020/21. Among the key commitments, the Government invested £31m in deploying 470 pharmacists in more than 700 practices, which will be supplemented by an additional The big question Unsuccessful cuts appeal: what next for pharmacists? The Court of Appeal’s decision to uphold the Government’s cuts came as yet another blow as the sector desperately waited for months in the hope of seeing the current funding arrangements reversed. It will take the profession much determination and boldness to make its case to the Department of Health and Social Care (DHSC) for proper remuneration, without which patients are likely to suffer. Hopefully, we will find a saviour in new Pharmaceutical Services Negotiating Committee (PSNC) chief executive Simon Duke, having a ‘naturally collaborative working approach’, as he put it in his interview with The Pharmacist (page 16). Pharmacists, we might have lost a battle but the war is far from over. What do you think? Tweet us at @Pharmacist_News September/October 2018 | The Pharmacist | 7